Who is sponsoring NCT05968274?

NCT05968274 is sponsored by Rebox Therapy s.r.o..

What drugs are being tested in NCT05968274?

Interventions in NCT05968274: Rebox-Physio 4 (real stimulation), Rebox-Physio 4 (sham stimulation).

What condition does NCT05968274 study?

NCT05968274 studies Electric Stimulation Therapy.

Is NCT05968274 still recruiting?

NCT05968274 is currently completed. Last updated 26 November 2024.

Last reviewed 2024-11-26 · How we verify

NCT05968274: REBOX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Rebox Current in Pain Management

Completed Phase 4 Last updated 26 November 2024

What this trial tests

Phase 4 trial testing Rebox-Physio 4 (real stimulation) in Electric Stimulation Therapy in 72 participants. Completed in 10 November 2024.

Timeline

1 October 2023

Primary endpoint
10 July 2024

10 November 2024

Quick facts

Lead sponsor	Rebox Therapy s.r.o.
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	72
Start date	1 October 2023
Primary completion	10 July 2024
Estimated completion	10 November 2024
Sites	1 location across Slovakia

Drugs / interventions tested

Rebox-Physio 4 (real stimulation)
Rebox-Physio 4 (sham stimulation)

Conditions studied

Electric Stimulation Therapy — all drugs for Electric Stimulation Therapy →

Sponsor

Rebox Therapy s.r.o.

Who can join

18 and older, any sex, with Electric Stimulation Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This post-marketing monocentric double-blind sham controlled crossover study will assess the efficacy of Rebox electrotherapy in the treatment of pain. Totally 72 patients will be treated with both real and sham Rebox device in a crossover design with a 1:1 ratio over a 6-week period. The degree of pain intensity reduction after the real Rebox stimulation will be evaluated in comparison with the sham stimulation. Moreover, differences in multidimensional aspects of pain will be compared between the real and sham stimulation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of Rebox Electrotherapy in Pain Management: A Randomized Double-Blind Sham-Controlled Crossover Trial.
Martuliak I, Chvála Ľ, Ferenčík M, Fabián V, et al · · 2025 · PMID 40900299 · DOI 10.1007/s40122-025-00768-w

Verify or expand the search:

Other recruiting trials for Electric Stimulation Therapy

Currently open trials in the same condition.

NCT06520020 — Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal · NA · recruiting
NCT00739362 — Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05968274 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rebox Therapy s.r.o.
Last refreshed: 26 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05968274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing